4.6 Review

DNA Methylation and Schizophrenia: Current Literature and Future Perspective

期刊

CELLS
卷 10, 期 11, 页码 -

出版社

MDPI
DOI: 10.3390/cells10112890

关键词

schizophrenia; DNA methylation; epigenetics; biomarkers

资金

  1. National Research Foundation Thuthuka [129827]
  2. Developing Research Innovation, Localisation and Leadership in South Africa (DRILL) [D43TW010131]

向作者/读者索取更多资源

Schizophrenia is a neuropsychiatric disorder characterized by dissociation of thoughts, ideas, identity, and emotions. It has no central pathophysiological mechanism and precise diagnostic markers. Despite its high heritability, there are also environmental factors implicated in the development of schizophrenia. Epigenetic factors, such as DNA methylation, are thought to mediate the effects of environmental factors in the development of the disorder.
Schizophrenia is a neuropsychiatric disorder characterized by dissociation of thoughts, idea, identity, and emotions. It has no central pathophysiological mechanism and precise diagnostic markers. Despite its high heritability, there are also environmental factors implicated in the development of schizophrenia. Epigenetic factors are thought to mediate the effects of environmental factors in the development of the disorder. Epigenetic modifications like DNA methylation are a risk factor for schizophrenia. Targeted gene approach studies attempted to find candidate gene methylation, but the results are contradictory. Genome-wide methylation studies are insufficient in literature and the available data do not cover different populations like the African populations. The current genome-wide studies have limitations related to the sample and methods used. Studies are required to control for these limitations. Integration of DNA methylation, gene expression, and their effects are important in the understanding of the development of schizophrenia and search for biomarkers. There are currently no precise and functional biomarkers for the disorder. Several epigenetic markers have been reported to be common in functional and peripheral tissue. This makes the peripheral tissue epigenetic changes a surrogate of functional tissue, suggesting common epigenetic alteration can be used as biomarkers of schizophrenia in peripheral tissue.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据